Assessing the Impact of Drug Safety Signals from the WHO Database Presented in ‘SIGNAL’: Results from a Questionnaire of National Pharmacovigilance Centres

Author： Ståhl M.   Edwards I.R.   Bowring G.   Kiuru A.   Lindquist M.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.26, Iss.10, 2003-01, pp. : 721-727

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Fever: A Descriptive Cohort Study from the French National Pharmacovigilance Database

By Vodovar Dominique   LeBeller Christine   Mégarbane Bruno   Lillo-Le-Louet Agnes   Hanslik Thomas  

Drug Safety, Vol. 35, Iss. 9, 2012-09 ,pp. : 759-767

Adis International

Access to resources Recommend Favorite

Bisphosphonate‐related osteonecrosis of the jaw: data from the French national pharmacovigilance database

By  

Fundamental & Clinical Pharmacology, Vol. 30, Iss. 5, 2016-10 ,pp. : 450-458

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Postgraduate Qualifications in Pharmacovigilance from the Drug Safety Research Unit in the UK

By Lynn Elizabeth   Layton Deborah   Shakir Saad  

Drug Safety, Vol. 34, Iss. 1, 2011-01 ,pp. : 89-91

Adis International

Access to resources Recommend Favorite

Uterine Perforation with the Levonorgestrel-Releasing Intrauterine Device: Analysis of Reports from Four National Pharmacovigilance Centres

By >   Sachs Bernhardt  

Drug Safety, Vol. 34, Iss. 1, 2011-01 ,pp. : 83-88

Adis International

Access to resources Recommend Favorite

Improving Global Monitoring of Vaccine Safety: A Survey of National Centres Participating in the WHO Programme for International Drug Monitoring

By Letourneau Megan   Wells George   Walop Wikke   Duclos Philippe  

Drug Safety, Vol. 31, Iss. 5, 2008-01 ,pp. : 389-398

Adis International

Access to resources Recommend Favorite